Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | XBP1 | P17861 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.42 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 6/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20243220 | 0.97 | CYP1A1 (0.48) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL20243218 | 0.95 | CYP1A1 (0.45) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL23126669 | 0.93 | CYP1A1 (0.53) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL21137707 | 0.92 | L3MBTL1 (0.47) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL16641506 | 0.92 | L3MBTL1 (0.47) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL18325336 | 0.90 | CYP1A1 (0.48) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL18325193 | 0.90 | CYP1A1 (0.48) | CYP1A1CYP1A2CYP1B1RAB9ANPC1 | |
| SCHEMBL22192847 | 0.90 | NR1I3 (0.54) | RAB9ANPC1L3MBTL1MAPTABCG2 | |
| SCHEMBL29776774 | 0.90 | MEN1 (0.47) | CYP1A2ATML3MBTL1MAPTLMNA | |
| SCHEMBL16641373 | 0.90 | MEN1 (0.47) | CYP1A2ATML3MBTL1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210083202-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-03-18 | — | — | US | disclosed |
| US-10897016-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-01-19 | — | — | US | disclosed |
| US-20180138425-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-17 | — | — | US | disclosed |
| US-20180138425-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180138425-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | DDT, OCIAD1, OCIAD2 | CYP1A1 1059/4885CYP1A2 677/4885CYP1B1 745/4885 |
| US-10897016-B2 | Organic electroluminescent materials and devices | DDT, OCIAD1, OCIAD2 | CYP1A1 1059/4885CYP1A2 677/4885CYP1B1 745/4885 |
| US-20210083202-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | DDT, OCIAD1, OCIAD2 | CYP1A1 1059/4885CYP1A2 677/4885CYP1B1 745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.